Xing R. Yang

Beijing, 100191, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Fluorogenic Heterodimers Enable Rapid Fluorescence Lifetime Imaging of Prostate-Specific Membrane Antigen-Positive Tumors.

Fluorogenic Heterodimers Enable Rapid Fluorescence Lifetime Imaging of Prostate-Specific Membrane Antigen-Positive Tumors.

Journal: ACS sensors

Published: April 21, 2026

Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types.

Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types.

Journal: Cell stem cell

Published: April 10, 2026

Development of a Novel 68Ga-Labeled Radiotracer Targeting Carbonic Anhydrase IX for the Diagnosis of Clear Cell Renal Cell Carcinoma.

Development of a Novel 68Ga-Labeled Radiotracer Targeting Carbonic Anhydrase IX for the Diagnosis of Clear Cell Renal Cell Carcinoma.

Journal: Molecular pharmaceutics

Published: February 02, 2026

Analysis of reproductive and psychological health of pregnant women with placenta accreta spectrum disorders after fertility-preserving treatment

Analysis of reproductive and psychological health of pregnant women with placenta accreta spectrum disorders after fertility-preserving treatment

Journal: Zhonghua fu chan ke za zhi

Published: January 29, 2026

Downregulation of TDP43 by atovaquone inhibits oxidative phosphorylation and enhances sensitivity of triple-negative breast cancer to EGFR-TKIs.

Downregulation of TDP43 by atovaquone inhibits oxidative phosphorylation and enhances sensitivity of triple-negative breast cancer to EGFR-TKIs.

Journal: Free radical biology & medicine

Published: January 03, 2026

Bioinformatics profiling of NECTIN4 in lung cancer and comparative evaluation of NECTIN4-targeted ⁶⁸Ga-N188 and ¹⁸F-FDG PET/CT.

Bioinformatics profiling of NECTIN4 in lung cancer and comparative evaluation of NECTIN4-targeted ⁶⁸Ga-N188 and ¹⁸F-FDG PET/CT.

Journal: Journal of translational medicine

Published: November 08, 2025

Development of a novel 18F-labeled radiotracer targeting granzyme B for imaging early tumor responses to immunotherapy.

Development of a novel 18F-labeled radiotracer targeting granzyme B for imaging early tumor responses to immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: October 28, 2025

Evaluation of INR101, a PSMA-Targeted 18F PET Tracer, for suspected prostate cancer: A multicenter phase I/IIa trial with histopathologic confirmation.

Evaluation of INR101, a PSMA-Targeted 18F PET Tracer, for suspected prostate cancer: A multicenter phase I/IIa trial with histopathologic confirmation.

Journal: EJNMMI research

Published: August 07, 2025

Theranostics targeting fibroblast activation protein in the pan-cancer field.

Theranostics targeting fibroblast activation protein in the pan-cancer field.

Journal: International journal of cancer

Published: March 17, 2025

Unveiling Macrophage Content as a Predictive Biomarker for Intraoperative ICG Imaging Efficacy in Lung Cancer.

Unveiling Macrophage Content as a Predictive Biomarker for Intraoperative ICG Imaging Efficacy in Lung Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 11, 2025

Dual-modality theranostics probes: sintegrative strategies for precision management of oncologic malignancies.

Dual-modality theranostics probes: sintegrative strategies for precision management of oncologic malignancies.

Journal: Life medicine

Published: March 08, 2025

Biomimetic NIR-II aggregation-induced emission nanoparticles for targeted photothermal therapy of ovarian cancer.

Biomimetic NIR-II aggregation-induced emission nanoparticles for targeted photothermal therapy of ovarian cancer.

Journal: Journal of materials chemistry. B

Published: March 06, 2025

Showing 1-12 of 73

Last Updated: 09/26/2026